Kuppe, Christoph http://orcid.org/0000-0003-4597-9833
Ramirez Flores, Ricardo O. http://orcid.org/0000-0003-0087-371X
Li, Zhijian http://orcid.org/0000-0002-1523-1333
Hayat, Sikander
Levinson, Rebecca T.
Liao, Xian
Hannani, Monica T. http://orcid.org/0000-0002-4123-6832
Tanevski, Jovan http://orcid.org/0000-0001-7177-1003
Wünnemann, Florian
Nagai, James S.
Halder, Maurice http://orcid.org/0000-0003-2386-9684
Schumacher, David http://orcid.org/0000-0002-2308-6543
Menzel, Sylvia
Schäfer, Gideon
Hoeft, Konrad http://orcid.org/0000-0002-0265-0061
Cheng, Mingbo
Ziegler, Susanne
Zhang, Xiaoting
Peisker, Fabian http://orcid.org/0000-0003-0123-8179
Kaesler, Nadine
Saritas, Turgay http://orcid.org/0000-0002-6691-9218
Xu, Yaoxian
Kassner, Astrid
Gummert, Jan
Morshuis, Michiel
Amrute, Junedh http://orcid.org/0000-0002-6851-0168
Veltrop, Rogier J. A. http://orcid.org/0000-0002-1386-820X
Boor, Peter http://orcid.org/0000-0001-9921-4284
Klingel, Karin
Van Laake, Linda W.
Vink, Aryan http://orcid.org/0000-0002-9371-8788
Hoogenboezem, Remco M.
Bindels, Eric M. J. http://orcid.org/0000-0001-9502-669X
Schurgers, Leon http://orcid.org/0000-0001-7867-6957
Sattler, Susanne http://orcid.org/0000-0001-9932-4109
Schapiro, Denis http://orcid.org/0000-0002-9391-5722
Schneider, Rebekka K.
Lavine, Kory http://orcid.org/0000-0003-1948-9945
Milting, Hendrik
Costa, Ivan G. http://orcid.org/0000-0003-2890-8697
Saez-Rodriguez, Julio http://orcid.org/0000-0002-8552-8976
Kramann, Rafael http://orcid.org/0000-0003-4048-6351
Article History
Received: 30 November 2020
Accepted: 29 June 2022
First Online: 10 August 2022
Competing interests
: The authors declare no competing interests directly related to this work. The authors however disclose unrelated funding, honorariums and ownership as follows: R.K. has grants from Travere Therapeutics, Galapagos, Chugai and Novo Nordisk and is a consultant for Bayer, Pfizer, Novo Nordisk and Gruenenthal. J.S.-R. reports funding from GSK and Sanofi and fees from Travere Therapeutics and Astex Therapeutics. K.L. has grants from Novartis and Amgen and receives consulting fees from Medtronic and Implicit Biosciences. I.G.C. has a grant from Illumina. L.S. has received grants from Bayer, Boehringer Ingelheim and Nattopharma, is consultant for ImmunoDiagnostics Systems (IDS) and is a shareholder in Coagulation Profile. L.W.V.L. reports consultancy fees to UMCU from Abbott, Medtronic, Vifor and Novartis.
Free to read: This content has been made available to all.